Bullishcharts

Bull flag forming in Abbott Labs $100 target on break.

NYSE:ABT   Abbott Laboratories
Upside target in the $100 region , earnings approaching in October could be the stimulus for that move.
ABT specialize in Diabetes, which is one of the fastest growing disease in the world, the potential growth for ABT in huge which is reflected in the increased hiring in its European bases.
As more of the world comes out of poverty, a unfortunate result is the rise in such diet related illnesses.
Company profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.